Novel Immunotherapy Developed by City of Hope Could Provide New Treatment Model for SARS-CoV-2 Patients

Natural killer (NK) cells engineered with chimeric antigen receptor (CAR) cells to better fight COVID-19 LOS ANGELES–(BUSINESS WIRE)–City of Hope researchers have engineered an immunotherapy using natural killer cells with a specific molecule that can target the SARS-CoV-2 virus’ spike protein, providing a novel therapeutic pathway for the treatment of COVID-19 and other infections that … [Read more…]

Global Dermatological Drug Market Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Dermatological Drug Market – Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Dermatological Drug Market is projected to grow at a CAGR of 11.22% during the forecast period to reach US$47.892 billion by 2027, up from US$22.747 billion in 2020. Dermatology is a field of medicine … [Read more…]

COVID-19 Boosters Now Available at Rite Aid and Bartell Drugs Locations for Eligible Children Ages 5 – 11

Appointments can be made online and walk-in appointments are available PHILADELPHIA–(BUSINESS WIRE)–Rite Aid (NYSE: RAD) today announced it will begin administering a booster dose of Pfizer’s COVID-19 vaccine at select locations for eligible children ages 5 to 11, following approval by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration … [Read more…]

New Private Practice FNS Opens, Providing Specialized Neuropsychology Evaluations for Children in Martin County

STUART, Fla.–(BUSINESS WIRE)–Florida Neuropsychology Specialists, LLC (FNS) recently opened its doors in Martin County. Dr. Morgan Koepper, board certified pediatric neuropsychologist and Clinical Director at FNS, is now accepting patients at her new office located near beautiful downtown Stuart, FL. FNS provides specialized neuropsychological evaluation of children, adolescents, and young adults. The team at FNS … [Read more…]

Aurinia Presents Results from the Two-Year AURORA 2 Continuation Study at the 2022 European Renal Association (ERA) Congress

Use of LUPKYNIS was safe and well tolerated in patients for up to three years of treatment, with no new safety signals In AURORA 2, long-term treatment with LUPKYNIS led to a clinically relevant preservation of kidney function in LN patients A pooled analysis from the AURA-LV and AURORA 1 studies, also presented at ERA, … [Read more…]

Eastern Bank Welcomes New Members To Its Board of Advisors and Board of Ambassadors

Members serve as community ambassadors in the communities Eastern serves BOSTON–(BUSINESS WIRE)–Eastern Bank is pleased to announce the election of five local community and business leaders to its Board of Advisors and Board of Ambassadors. The newly elected Advisors are: – Carolina Alarco, Founder and Principal, Bio Strategy Advisors LLC, and – Michael A. Curry, … [Read more…]

United States Anxiety Drugs (Generic and Patent Medicine) Market Research Report 2022-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Anxiety Drugs Market Research Report by Type (Generic Drugs and Patent Medicine), Application, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The United States Anxiety Drugs Market size was estimated at USD 3,023.13 million in 2021, USD 3,448.71 million in 2022, and … [Read more…]

World Social Anxiety Disorder (SAD) Epidemiology Forecast/Analysis Report 2022-2032 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Social Anxiety Disorder (SAD) – Epidemiology Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This “Social Anxiety Disorder (SAD) – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Social Anxiety Disorder (SAD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, … [Read more…]

Global Acute Social Anxiety Disorder Epidemiology Forecasts Report 2022-2032 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Acute Social Anxiety Disorder- Epidemiology Forecast to 2032” report has been added to ResearchAndMarkets.com’s offering. This “Acute Social Anxiety Disorder – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Acute Social Anxiety Disorder epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, … [Read more…]

General Anxiety Disorder (GAD) Epidemiology Forecasts, 2032 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “General Anxiety Disorder (GAD) – Epidemiology Forecast to 2032” report has been added to ResearchAndMarkets.com’s offering. This “General Anxiety Disorder (GAD) – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted General Anxiety Disorder (GAD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, … [Read more…]